The Effects of Aging and Estrogen on the Pituitary
The Effect of Aging on the Isolated Pituitary Response to Gonadotropin Releasing Hormone at Baseline and With Low Dose Estrogen Administration
Sponsor: Massachusetts General Hospital
This PHASE2/PHASE3 trial investigates Healthy and is currently ongoing. Massachusetts General Hospital leads this study, which shows 10 recorded versions since 2002 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Jan 2026 — Present [monthly]
Unknown PHASE2/PHASE3
-
Sep 2024 — Present [monthly]
Unknown PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2/PHASE3
Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status PHASE2_PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status PHASE2_PHASE3
▶ Show 5 earlier versions
-
May 2019 — Jan 2021 [monthly]
Unknown Status PHASE2_PHASE3
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — May 2019 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
May 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Feb 2017 — May 2017 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE2_PHASE3
First recorded
Jan 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
- National Institute on Aging (NIA)
For direct contact, visit the study record on ClinicalTrials.gov .